Strategic guidance bridging science, engineering, and commercialization for medical device and diagnostics innovators.
20+ years of R&D leadership • Ivy League postdoctoral training • Commercialization expertise
Execution Focus
Leadership Expertise
Medical innovation is more than good science. It requires clear decisions, experienced leadership, and a practical path forward. We help innovators move confidently from early ideas to real-world medical solutions.
Strategic medical technology leadership built on deep scientific training and real-world commercialization experience.
Fractional CTO | Diagnostics Evangelist | Commercialization Advisor
Michael Harman, PhD brings over 20 years of combined experience across R&D, executive support, and team leadership in the medical technology sector. His career began with an Ivy League clinical postdoctoral fellowship at Brown University and Rhode Island Hospital, where he developed the foundation for translating deep scientific research into practical solutions.
Since then, he has focused on helping innovators bridge the gap between laboratory discoveries and commercial medical products. His expertise spans product strategy, regulatory navigation, and launch execution—with a consistent focus on delivering measurable value to both clients and their investors.
Michael partners with startups, established innovators, and leadership teams to provide the strategic guidance needed to move from concept to market with confidence.
Years of Experience
Postdoctoral Training
We combine deep scientific understanding with practical industry experience, ensuring every decision supports progress, clarity, and real-world impact.
Michael is a valuable partner. I would gladly work with him again.
Michael brings strong expertise across product development and commercialization. His leadership, clear communication, and ability to motivate teams consistently drive strong outcomes.
Michael has most recently connected me with a valuable strategic connection for my company fundraising efforts.
Michael was a trusted adviser who consistently brought clarity to complex technologies. His clear communication and reliable guidance played a key role in winning competitive development programs.
Michael brings deep life sciences expertise and a rare ability to connect technology, engineering, and science. His leadership and insight consistently drive meaningful innovation across the biomedical field.
Mike is an exceptional connector with a rare ability to bring the right people together to solve complex problems. His insight, proactive support, and genuine commitment to helping others succeed have had a meaningful impact on my career and many others.
Mike is deeply driven by helping others succeed and advancing meaningful medical innovation. His passion, selflessness, and ability to elevate the work of those around him make him an exceptional force in the medical technology community.
Michael quickly understands where you are and adapts his guidance with clarity and ease. His expertise and steady approach made our work efficient, valuable, and confidence-building.
Founders, executives, and investors share their experiences working with strategic medical leadership focused on execution, clarity, and results.
Get clear, senior-level guidance to move medical technologies forward with confidence and focus.
Strategic partnership for teams ready to move from vision to execution.
Answers to the questions founders, leadership teams and investors ask most often.
A Fractional CTO gives your company senior technical leadership without the cost of a full time executive hire. That can include setting technical direction, overseeing product development, aligning your team around priorities, and reducing technical risk as you move toward market.
Common moments include preparing for a funding round, facing technical due diligence, approaching a regulatory milestone, struggling with unclear development priorities, or needing experienced leadership before hiring a permanent CTO.
Diagnostics is a core area of expertise, but I also work with medical device, medical technology and life sciences teams facing similar development and commercialization challenges.
Early stage MedTech startups, technical founders who need executive guidance, leadership teams preparing to scale, and investors who want an independent technical perspective on a company’s readiness and risk.
Yes. Support can include strengthening your technical positioning, building an investor ready roadmap, preparing for due diligence, and making strategic introductions to partners and investors.
We talk about your technology, where your company is today, your goals, and the biggest risks or decisions in front of you. The aim is to identify where experienced leadership could make the biggest difference, with no obligation.
Every engagement starts with understanding your technology and current stage. From there we define a clear path forward, I provide hands on leadership through execution, and we prepare the business for growth, partnerships and investment.
My background combines Ivy League clinical postdoctoral training at Brown University and Rhode Island Hospital with more than 20 years of R&D leadership and commercialization experience. This professional pathway empowers me to connect directly with scientific founders where they are in the lab or clinic without requiring any onboarding or training. The focus is on real MedTech decisions and execution, not generic accelerator advice.
Yes. Strategic introductions are an integral focus of how I help clients, whether that’s connecting you with investors, development partners, or experts across the life sciences ecosystem.
Insights on commercialization strategy, drug development, and bridging the gap between research and real-world impact.
